{'fraction_non_alphanumeric': 0.0218408736349454, 'fraction_numerical': 0.0062402496099844, 'mean_word_length': 5.415, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
When the cancer patient presents intractable pain

When the cancer patient presents symptoms of intractable pain, the health care team faces a complex challenge: determining the etiology of the patient's pain, assessing its severity, mapping its cyclic flow, factoring the psychological stresses contributing to the pain, and, finally, crafting a pain management approach uniquely suited to the individual needs. All too often, intractable pain in the cancer patient is a complex mixture of chronic pain coupled with recurrent episodes of acute pain. All this tests the resourcefulness of the health care team. Often, after the analytic analgesics and the traditional methods for administering them are found wanting, what the pain management team looks for is a more flexible, individualized method of addressing patients' needs. In 1985, the Medaday Oncology Program at Bethesda Lutheran Hospital, St. Paul, Minnesota, found an appropriate method to manage the chronic/acute pain complex. In December 1985 the Bethesda oncology specialist team began to apply a particular type of computerized amulatory infusion therapy to patients with this chronic/acute pain complex. The method found effective is a set hourly infusion rate combined with patient controlled incremental dosages.